查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2016160

組織學和細胞學市場報告：按產品類型、檢測類型、應用和地區分類（2026-2034 年）

Histology and Cytology Market Report by Product, Type of Examination, Test Type, Application, and Region 2026-2034
出版日期: | 出版商: IMARC | 英文 144 Pages | 商品交期: 2-3個工作天內

價格

2025年，全球組織學和細胞學市場規模達199億美元。展望未來，IMARC Group預測，到2034年，該市場規模將達到431億美元，2026年至2034年的複合年成長率為8.69%。對疾病早期檢測需求的不斷成長，以及對先進治療方法的日益了解，正在推動市場成長。

組織學與細胞學市場趨勢：

人工智慧整合的技術進步

人工智慧的融合正在變革組織學和細胞學，使病理切片的分析更加精準。此外，將先進的成像技術與人工智慧驅動的工具相結合，提高了異常細胞檢測的準確性，從而減少了人為誤差。這些創新也簡化了流程，讓診斷更加快速可靠。因此，它們惠及檢查室和醫療機構，推動了組織學和細胞學市場的成長。例如，2024年8月，Modella AI發布了多模態平台模型和生成式人工智慧輔助工具，包括PathChat 2，旨在提高病理診斷的準確性。這些創新透過任務自動化、效率提升以及病理影像與臨床數據的整合進行綜合分析，正在革新市場。

提高診斷準確性和效率

影像技術的進步和工作流程自動化提高了組織學和細胞學診斷的準確性。此外，更快地檢測出異常情況可以減少假陰性結果，並實現早期療育。這也有助於改善患者的治療效果，因為醫療專業人員可以更快、更自信地做出更明智的決策。例如，Hologic公司於2024年2月推出了獲得FDA核准的“genius數位診斷系統”，這是首個結合人工智慧和先進成像技術的數位細胞學平台，用於子宮頸癌篩檢。該系統可將假陰性率降低約28%，最佳化工作流程，實現遠端協作，並提高組織學和細胞學診斷的準確性。

對數位病理解決方案的需求日益成長

擴充性、遠端存取和安全解決方案日益成長的需求正在推動數位化病理學的轉型。同時，檢查室和醫療機構正在採用數位化平台，以簡化資料存取、集中工作流程並加強專家間的協作，從而提高研究和臨床效率，同時確保病理資訊的安全處理。例如，2024年10月，HistoWiz發布了先進的FFPE組織區塊管理解決方案，作為其PathologyMap 2.0平台的一部分。該解決方案提供全天候的組織樣本數位化存取、安全儲存、快速組織學服務和整合工作流程，從而提高組織學和細胞學研究的效率和安全性。

目錄

第1章：序言

第2章：調查方法

  • 調查目的
  • 相關利益者
  • 數據來源
    • 主要訊息
    • 次要訊息
  • 市場估值
    • 自下而上的方法
    • 自上而下的方法
  • 預測方法

第3章執行摘要

第4章：引言

第5章：全球組織學與細胞學市場

  • 市場概覽
  • 市場表現
  • 新冠疫情的影響
  • 市場預測

第6章 市場區隔：依產品分類

  • 儀器和分析軟體系統
  • 耗材和試劑

第7章 市場區隔：依測試類型分類

  • 組織學
  • 細胞學

第8章 市場區隔：依測試類型分類

  • 顯微鏡檢查
  • 分子遺傳學檢測
  • 流式細胞技術

第9章 市場區隔：依應用領域分類

  • 藥物發現與設計
  • 臨床診斷
    • 主要部分
      • 即時偵測 (PoC)
      • 非即時護理
  • 研究

第10章 市場區隔：依地區分類

  • 北美洲
    • 美國
    • 加拿大
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 韓國
    • 澳洲
    • 印尼
    • 其他
  • 歐洲
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙
    • 俄羅斯
    • 其他
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 其他
  • 中東和非洲

第11章 SWOT 分析

第12章：價值鏈分析

第13章：波特五力分析

第14章：價格分析

第15章 競爭格局

  • 市場結構
  • 主要企業
  • 主要企業簡介
    • Abbott Laboratories
    • Becton Dickinson and Company
    • Carl Zeiss AG
    • Danaher Corporation
    • F. Hoffmann-La Roche AG
    • Hologic Inc.
    • Koninklijke Philips NV
    • Merck KGaA
    • Olympus Corporation
    • PerkinElmer Inc.
    • Sysmex Corporation
    • Thermo Fisher Scientific Inc.
    • Trivitron Healthcare
Product Code: SR112026A5706

The global histology and cytology market size reached USD 19.9 Billion in 2025. Looking forward, IMARC Group expects the market to reach USD 43.1 Billion by 2034, exhibiting a growth rate (CAGR) of 8.69% during 2026-2034. The increasing demand for early disease detection, along with the rising awareness about advanced therapeutics, is propelling the market.

HISTOLOGY AND CYTOLOGY MARKET ANALYSIS:

  • Major Market Drivers: The growing advancements in diagnostic technology are making these tests more efficient, thereby propelling the market.
  • Key Market Trends: The rising awareness about cancer screening is leading to higher utilization of these tests, which is acting as a significant growth-inducing factor.
  • Competitive Landscape: Some of the major market companies include Abbott Laboratories, Becton Dickinson and Company, Carl Zeiss AG, Danaher Corporation, F. Hoffmann-La Roche AG, Hologic Inc., Koninklijke Philips N.V., Merck KGaA, Olympus Corporation, PerkinElmer Inc., Sysmex Corporation, Thermo Fisher Scientific Inc., and Trivitron Healthcare, among many others.
  • Geographical Trends: North America exhibits a clear dominance in the market due to advanced healthcare infrastructure and rising cancer cases, along with the increasing demand for diagnostic services in pathology labs.
  • Challenges and Opportunities: The limited accessibility and high costs are hindering the market. However, technological advancements and expanded training programs to improve efficiency and affordability will continue to strengthen the market over the forecast period.

HISTOLOGY AND CYTOLOGY MARKET TRENDS:

Technological Advancements in AI Integration

AI integration is transforming histology and cytology by enabling more precise analysis of pathology slides. Moreover, advanced imaging techniques paired with AI-driven tools improve the detection of abnormal cells, thereby reducing manual errors. Furthermore, these innovations streamline processes, thereby making diagnoses quicker and more reliable. Thus, benefiting laboratories and healthcare providers and driving histology and cytology market growth. For instance, in August 2024, Modella AI launched multimodal foundation models and generative AI copilots, including PathChat 2, to enhance diagnostic accuracy in pathology. These innovations revolutionize the market by automating tasks, improving efficiency, and integrating pathology images with clinical data for comprehensive analysis.

Improved Diagnostic Accuracy and Efficiency

Enhanced imaging technologies and automated workflows are increasing the accuracy of diagnoses in histology and cytology. In addition, faster detection of abnormalities ensures early intervention while reducing false negatives. Also, this results in better patient outcomes, as medical professionals can make more informed decisions with greater confidence and in less time. For instance, in February 2024, Hologic launched the FDA-cleared genius digital diagnostics system, the first digital cytology platform combining AI with advanced imaging for cervical cancer screening. It reduces false negatives by approximately 28%, improves workflow, and enables remote collaboration for enhanced diagnostic accuracy in histology and cytology.

Growing Demand for Digital Pathology Solutions

The need for scalable, remote, and secure solutions drives the shift towards digital pathology. In contrast, laboratories and healthcare institutions are adopting digital platforms for easy access to data, centralized workflows, and enhanced collaboration among professionals, which improves research and clinical efficiency while ensuring the secure handling of pathology information. For instance, in October 2024, HistoWiz launched its advanced FFPE block management solution as part of the PathologyMap 2.0 platform. This solution offers 24/7 digital access to tissue samples, secure storage, rapid histology services, and integrated workflows, enhancing efficiency and security in histology and cytology research.

GLOBAL HISTOLOGY AND CYTOLOGY INDUSTRY SEGMENTATION:

Breakup by Product:

  • Instruments and Analysis Software System
  • Consumable and Reagents

Consumable and reagents currently dominate the market

Consumables and reagents exhibit a clear dominance in the market, with significant growth driven by the regular need for replenishing consumables during diagnostic procedures. For example, Hologic's ThinPrep Pap Test reagents have become widely adopted in cytology for detecting cervical abnormalities.

Breakup by Type of Examination:

  • Histology
  • Cytology

Cytology currently dominates the market

Cytology, lead the market, which is driven by focusing on the study of individual cell structures, often surpasses histology in faster diagnostics. For example, fine needle aspiration cytology is widely used in cancer screening due to its minimally invasive nature and quick results.

Breakup by Test Type:

  • Microscopy Tests
  • Molecular Genetics Tests
  • Flow Cytometry

Microscopy tests currently dominates the market

Microscopy tests dominate the market, offering precise cellular analysis. For example, Roche's Digital Pathology portfolio enhances efficiency by integrating AI in microscope testing, thereby helping pathologists detect abnormalities in tissue samples more accurately and quickly than traditional methods.

Breakup by Application:

  • Drug Discovery and Designing
  • Clinical Diagnostics
    • Point-of-Care (PoC)
    • Non-Point-of-Care
  • Research

Drug discovery and designing currently hold the largest histology and cytology market share

Drug discovery and designing leads the market, as they play a significant role in histology and cytology by enabling the identification of cellular changes in response to new compounds. For instance, PerkinElmer's launch of advanced imaging systems accelerates these processes by providing detailed cellular analysis for drug development.

Breakup by Region:

  • North America
    • United States
    • Canada
  • Asia-Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Indonesia
    • Others
  • Europe
    • Germany
    • France
    • United Kingdom
    • Italy
    • Spain
    • Russia
    • Others
  • Latin America
    • Brazil
    • Mexico
    • Others
  • Middle East and Africa

North America currently dominates the market

The market outlook report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America accounted for the largest histology and cytology market share.

North America dominates the market, which is driven by advanced healthcare infrastructure and high adoption of diagnostic technologies. In addition, the presence of key industry players, like Hologic and Becton Dickinson, fuels innovation and product launches. For example, Hologic's Panther Fusion system, offering advanced molecular diagnostics, highlights the region's focus on expanding diagnostic capabilities. Also, favorable government initiatives and a rising number of cancer cases support the market's growth, making North America a leader in histology and cytology advancements.

COMPETITIVE LANDSCAPE:

The market research report has provided a comprehensive analysis of the competitive landscape. Detailed profiles of all market companies have also been provided. Some of the key players in the market include:

  • Abbott Laboratories
  • Becton Dickinson and Company
  • Carl Zeiss AG
  • Danaher Corporation
  • F. Hoffmann-La Roche AG
  • Hologic Inc.
  • Koninklijke Philips N.V.
  • Merck KGaA
  • Olympus Corporation
  • PerkinElmer Inc.
  • Sysmex Corporation
  • Thermo Fisher Scientific Inc.
  • Trivitron Healthcare

KEY QUESTIONS ANSWERED IN THIS REPORT

1. What was the size of the global histology and cytology market in 2025?

2. What is the expected growth rate of the global histology and cytology market during 2026-2034?

3. What are the key factors driving the global histology and cytology market?

4. What has been the impact of COVID-19 on the global histology and cytology market growth?

5. What is the breakup of the global histology and cytology market based on the product?

6. What is the breakup of the global histology and cytology market based on the type of examination?

7. What is the breakup of the global histology and cytology market based on test type?

8. What is the breakup of the global histology and cytology market based on the application?

9. What are the key regions in the global histology and cytology market?

10. Who are the key players/companies in the global histology and cytology market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Histology and Cytology Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Product

  • 6.1 Instruments and Analysis Software System
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Consumable and Reagents
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast

7 Market Breakup by Type of Examination

  • 7.1 Histology
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Cytology
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast

8 Market Breakup by Test Type

  • 8.1 Microscopy Tests
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Molecular Genetics Tests
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Flow Cytometry
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast

9 Market Breakup by Application

  • 9.1 Drug Discovery and Designing
    • 9.1.1 Market Trends
    • 9.1.2 Market Forecast
  • 9.2 Clinical Diagnostics
    • 9.2.1 Market Trends
    • 9.2.2 Key Segments
      • 9.2.2.1 Point-of-Care (PoC)
      • 9.2.2.2 Non-Point-of-Care
    • 9.2.3 Market Forecast
  • 9.3 Research
    • 9.3.1 Market Trends
    • 9.3.2 Market Forecast

10 Market Breakup by Region

  • 10.1 North America
    • 10.1.1 United States
      • 10.1.1.1 Market Trends
      • 10.1.1.2 Market Forecast
    • 10.1.2 Canada
      • 10.1.2.1 Market Trends
      • 10.1.2.2 Market Forecast
  • 10.2 Asia-Pacific
    • 10.2.1 China
      • 10.2.1.1 Market Trends
      • 10.2.1.2 Market Forecast
    • 10.2.2 Japan
      • 10.2.2.1 Market Trends
      • 10.2.2.2 Market Forecast
    • 10.2.3 India
      • 10.2.3.1 Market Trends
      • 10.2.3.2 Market Forecast
    • 10.2.4 South Korea
      • 10.2.4.1 Market Trends
      • 10.2.4.2 Market Forecast
    • 10.2.5 Australia
      • 10.2.5.1 Market Trends
      • 10.2.5.2 Market Forecast
    • 10.2.6 Indonesia
      • 10.2.6.1 Market Trends
      • 10.2.6.2 Market Forecast
    • 10.2.7 Others
      • 10.2.7.1 Market Trends
      • 10.2.7.2 Market Forecast
  • 10.3 Europe
    • 10.3.1 Germany
      • 10.3.1.1 Market Trends
      • 10.3.1.2 Market Forecast
    • 10.3.2 France
      • 10.3.2.1 Market Trends
      • 10.3.2.2 Market Forecast
    • 10.3.3 United Kingdom
      • 10.3.3.1 Market Trends
      • 10.3.3.2 Market Forecast
    • 10.3.4 Italy
      • 10.3.4.1 Market Trends
      • 10.3.4.2 Market Forecast
    • 10.3.5 Spain
      • 10.3.5.1 Market Trends
      • 10.3.5.2 Market Forecast
    • 10.3.6 Russia
      • 10.3.6.1 Market Trends
      • 10.3.6.2 Market Forecast
    • 10.3.7 Others
      • 10.3.7.1 Market Trends
      • 10.3.7.2 Market Forecast
  • 10.4 Latin America
    • 10.4.1 Brazil
      • 10.4.1.1 Market Trends
      • 10.4.1.2 Market Forecast
    • 10.4.2 Mexico
      • 10.4.2.1 Market Trends
      • 10.4.2.2 Market Forecast
    • 10.4.3 Others
      • 10.4.3.1 Market Trends
      • 10.4.3.2 Market Forecast
  • 10.5 Middle East and Africa
    • 10.5.1 Market Trends
    • 10.5.2 Market Breakup by Country
    • 10.5.3 Market Forecast

11 SWOT Analysis

  • 11.1 Overview
  • 11.2 Strengths
  • 11.3 Weaknesses
  • 11.4 Opportunities
  • 11.5 Threats

12 Value Chain Analysis

13 Porters Five Forces Analysis

  • 13.1 Overview
  • 13.2 Bargaining Power of Buyers
  • 13.3 Bargaining Power of Suppliers
  • 13.4 Degree of Competition
  • 13.5 Threat of New Entrants
  • 13.6 Threat of Substitutes

14 Price Analysis

15 Competitive Landscape

  • 15.1 Market Structure
  • 15.2 Key Players
  • 15.3 Profiles of Key Players
    • 15.3.1 Abbott Laboratories
      • 15.3.1.1 Company Overview
      • 15.3.1.2 Product Portfolio
      • 15.3.1.3 Financials
      • 15.3.1.4 SWOT Analysis
    • 15.3.2 Becton Dickinson and Company
      • 15.3.2.1 Company Overview
      • 15.3.2.2 Product Portfolio
      • 15.3.2.3 Financials
      • 15.3.2.4 SWOT Analysis
    • 15.3.3 Carl Zeiss AG
      • 15.3.3.1 Company Overview
      • 15.3.3.2 Product Portfolio
      • 15.3.3.3 SWOT Analysis
    • 15.3.4 Danaher Corporation
      • 15.3.4.1 Company Overview
      • 15.3.4.2 Product Portfolio
      • 15.3.4.3 Financials
      • 15.3.4.4 SWOT Analysis
    • 15.3.5 F. Hoffmann-La Roche AG
      • 15.3.5.1 Company Overview
      • 15.3.5.2 Product Portfolio
      • 15.3.5.3 Financials
    • 15.3.6 Hologic Inc.
      • 15.3.6.1 Company Overview
      • 15.3.6.2 Product Portfolio
      • 15.3.6.3 Financials
      • 15.3.6.4 SWOT Analysis
    • 15.3.7 Koninklijke Philips N.V.
      • 15.3.7.1 Company Overview
      • 15.3.7.2 Product Portfolio
      • 15.3.7.3 Financials
      • 15.3.7.4 SWOT Analysis
    • 15.3.8 Merck KGaA
      • 15.3.8.1 Company Overview
      • 15.3.8.2 Product Portfolio
      • 15.3.8.3 Financials
      • 15.3.8.4 SWOT Analysis
    • 15.3.9 Olympus Corporation
      • 15.3.9.1 Company Overview
      • 15.3.9.2 Product Portfolio
      • 15.3.9.3 Financials
      • 15.3.9.4 SWOT Analysis
    • 15.3.10 PerkinElmer Inc.
      • 15.3.10.1 Company Overview
      • 15.3.10.2 Product Portfolio
      • 15.3.10.3 Financials
      • 15.3.10.4 SWOT Analysis
    • 15.3.11 Sysmex Corporation
      • 15.3.11.1 Company Overview
      • 15.3.11.2 Product Portfolio
      • 15.3.11.3 Financials
      • 15.3.11.4 SWOT Analysis
    • 15.3.12 Thermo Fisher Scientific Inc.
      • 15.3.12.1 Company Overview
      • 15.3.12.2 Product Portfolio
      • 15.3.12.3 Financials
      • 15.3.12.4 SWOT Analysis
    • 15.3.13 Trivitron Healthcare
      • 15.3.13.1 Company Overview
      • 15.3.13.2 Product Portfolio

List of Figures

  • Figure 1: Global: Histology and Cytology Market: Major Drivers and Challenges
  • Figure 2: Global: Histology and Cytology Market: Sales Value (in Billion USD), 2020-2025
  • Figure 3: Global: Histology and Cytology Market Forecast: Sales Value (in Billion USD), 2026-2034
  • Figure 4: Global: Histology and Cytology Market: Breakup by Product (in %), 2025
  • Figure 5: Global: Histology and Cytology Market: Breakup by Type of Examination (in %), 2025
  • Figure 6: Global: Histology and Cytology Market: Breakup by Test Type (in %), 2025
  • Figure 7: Global: Histology and Cytology Market: Breakup by Application (in %), 2025
  • Figure 8: Global: Histology and Cytology Market: Breakup by Region (in %), 2025
  • Figure 9: Global: Histology and Cytology (Instruments and Analysis Software System) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 10: Global: Histology and Cytology (Instruments and Analysis Software System) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 11: Global: Histology and Cytology (Consumable and Reagents) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 12: Global: Histology and Cytology (Consumable and Reagents) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 13: Global: Histology and Cytology (Histology) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 14: Global: Histology and Cytology (Histology) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 15: Global: Histology and Cytology (Cytology) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 16: Global: Histology and Cytology (Cytology) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 17: Global: Histology and Cytology (Microscopy Tests) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 18: Global: Histology and Cytology (Microscopy Tests) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 19: Global: Histology and Cytology (Molecular Genetics Tests) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 20: Global: Histology and Cytology (Molecular Genetics Tests) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 21: Global: Histology and Cytology (Flow Cytometry) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 22: Global: Histology and Cytology (Flow Cytometry) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 23: Global: Histology and Cytology (Drug Discovery and Designing) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 24: Global: Histology and Cytology (Drug Discovery and Designing) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 25: Global: Histology and Cytology (Clinical Diagnostics) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 26: Global: Histology and Cytology (Clinical Diagnostics) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 27: Global: Histology and Cytology (Research) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 28: Global: Histology and Cytology (Research) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 29: North America: Histology and Cytology Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 30: North America: Histology and Cytology Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 31: United States: Histology and Cytology Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 32: United States: Histology and Cytology Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 33: Canada: Histology and Cytology Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 34: Canada: Histology and Cytology Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 35: Asia-Pacific: Histology and Cytology Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 36: Asia-Pacific: Histology and Cytology Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 37: China: Histology and Cytology Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 38: China: Histology and Cytology Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 39: Japan: Histology and Cytology Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 40: Japan: Histology and Cytology Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 41: India: Histology and Cytology Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 42: India: Histology and Cytology Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 43: South Korea: Histology and Cytology Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 44: South Korea: Histology and Cytology Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 45: Australia: Histology and Cytology Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 46: Australia: Histology and Cytology Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 47: Indonesia: Histology and Cytology Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 48: Indonesia: Histology and Cytology Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 49: Others: Histology and Cytology Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 50: Others: Histology and Cytology Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 51: Europe: Histology and Cytology Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 52: Europe: Histology and Cytology Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 53: Germany: Histology and Cytology Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 54: Germany: Histology and Cytology Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 55: France: Histology and Cytology Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 56: France: Histology and Cytology Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 57: United Kingdom: Histology and Cytology Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 58: United Kingdom: Histology and Cytology Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 59: Italy: Histology and Cytology Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 60: Italy: Histology and Cytology Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 61: Spain: Histology and Cytology Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 62: Spain: Histology and Cytology Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 63: Russia: Histology and Cytology Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 64: Russia: Histology and Cytology Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 65: Others: Histology and Cytology Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 66: Others: Histology and Cytology Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 67: Latin America: Histology and Cytology Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 68: Latin America: Histology and Cytology Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 69: Brazil: Histology and Cytology Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 70: Brazil: Histology and Cytology Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 71: Mexico: Histology and Cytology Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 72: Mexico: Histology and Cytology Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 73: Others: Histology and Cytology Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 74: Others: Histology and Cytology Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 75: Middle East and Africa: Histology and Cytology Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 76: Middle East and Africa: Histology and Cytology Market: Breakup by Country (in %), 2025
  • Figure 77: Middle East and Africa: Histology and Cytology Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 78: Global: Histology and Cytology Industry: SWOT Analysis
  • Figure 79: Global: Histology and Cytology Industry: Value Chain Analysis
  • Figure 80: Global: Histology and Cytology Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Histology and Cytology Market: Key Industry Highlights, 2025 and 2034
  • Table 2: Global: Histology and Cytology Market Forecast: Breakup by Product (in Million USD), 2026-2034
  • Table 3: Global: Histology and Cytology Market Forecast: Breakup by Type of Examination (in Million USD), 2026-2034
  • Table 4: Global: Histology and Cytology Market Forecast: Breakup by Test Type (in Million USD), 2026-2034
  • Table 5: Global: Histology and Cytology Market Forecast: Breakup by Application (in Million USD), 2026-2034
  • Table 6: Global: Histology and Cytology Market Forecast: Breakup by Region (in Million USD), 2026-2034
  • Table 7: Global: Histology and Cytology Market: Competitive Structure
  • Table 8: Global: Histology and Cytology Market: Key Players